Welcome to Taro Canada

Our Mission

Taro is a multinational; science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

AODA Compliance

Press Releases

December 23, 2016
Taro Announces Sale of U.S. Rights to Keveyis® to Strongbridge Biopharma plc

December 01, 2016
Taro Announces Appointment of Interim CEO

November 23, 2016
Taro Announces New $250 Million Share Repurchase Authorization

November 22, 2016
Taro Announces Appointment of New CEO and New Board Member Nominations

November 08, 2016
Taro Provides Results for September 30, 2016

October 31, 2016
Taro to Announce Second Quarter Results on November 8, 2016

Privacy Statement   |   Terms of Use   |   Safe Harbor   |   Useful Taro Links   |   Reporting Adverse Events